01 1LONZEAL PHARMACEUTICALS CO LTD
01 1LAMIVUDINE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-05-31
Pay. Date : 2018-05-04
DMF Number : 22982
Submission : 2009-07-21
Status : Active
Type : II
20
Shijiazhuang Lonzeal Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is LAMIVUDINE, with a corresponding US DMF Number 22982.
Remarkably, this DMF maintains an Active status since its submission on July 21, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 31, 2018, and payment made on May 04, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
